Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 371

1.

Novel Intermittent Dosing Burst Paradigm in Spinal Cord Stimulation.

Deer TR, Patterson DG, Baksh J, Pope JE, Mehta P, Raza A, Agnesi F, Chakravarthy KV.

Neuromodulation. 2020 Mar 23. doi: 10.1111/ner.13143. [Epub ahead of print]

PMID:
32202044
2.

Giant calcinosis in dermatomyositis/scleroderma overlap.

Fernández-Codina A, Camprodon-Gómez M, Pope JE.

Arthritis Rheumatol. 2020 Mar 17. doi: 10.1002/art.41262. [Epub ahead of print]

PMID:
32182400
3.

Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse systemic sclerosis: reply.

Nevskaya T, Zheng B, Baxter C, Ramey D, Pope JE, Baron M.

Rheumatology (Oxford). 2020 Mar 11. pii: keaa083. doi: 10.1093/rheumatology/keaa083. [Epub ahead of print] No abstract available.

PMID:
32160293
4.

Response to letter: "Nonlinear" burst stimulation by Richard North, MD.

Pope JE.

Neuromodulation. 2020 Feb;23(2):262-263. doi: 10.1111/ner.13123. No abstract available.

PMID:
32103590
5.

A Systematic Literature Review of Spine Neurostimulation Therapies for the Treatment of Pain.

Deer TR, Grider JS, Lamer TJ, Pope JE, Falowski S, Hunter CW, Provenzano DA, Slavin KV, Russo M, Carayannopoulos A, Shah JM, Harned ME, Hagedorn JM, Bolash RB, Arle JE, Kapural L, Amirdelfan K, Jain S, Liem L, Carlson JD, Malinowski MN, Bendel M, Yang A, Aiyer R, Valimahomed A, Antony A, Craig J, Fishman MA, Al-Kaisy AA, Christelis N, Rosenquist RW, Levy RM, Mekhail N.

Pain Med. 2020 Feb 8. pii: pnz353. doi: 10.1093/pm/pnz353. [Epub ahead of print]

PMID:
32034422
6.

Possible benefit of tadalafil cream for the treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis.

Fernández-Codina A, Kazem M, Pope JE.

Clin Rheumatol. 2020 Mar;39(3):963-965. doi: 10.1007/s10067-020-04966-z. Epub 2020 Feb 3. No abstract available.

PMID:
32016657
7.

Recommendations for the Treatment of Systemic Sclerosis: Agreement May Not Translate into Uptake.

Pope JE.

J Rheumatol. 2020 Feb;47(2):164-165. doi: 10.3899/jrheum.190582. No abstract available.

PMID:
32007942
8.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.

Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655. doi: 10.1136/annrheumdis-2019-216655. [Epub ahead of print]

9.

Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort.

Ellingwood L, Schieir O, Valois MF, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon C, Keystone EC, Tin D, Thorne C, Bykerk VP, Pope JE; CATCH Investigators.

ACR Open Rheumatol. 2019 Oct 21;1(10):614-619. doi: 10.1002/acr2.11086. eCollection 2019 Dec.

10.

Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial.

Mekhail N, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, Hunter CW, Rosen SM, Costandi SJ, Falowski SM, Burgher AH, Pope JE, Gilmore CA, Qureshi FA, Staats PS, Scowcroft J, Carlson J, Kim CK, Yang MI, Stauss T, Poree L; Evoke Study Group.

Lancet Neurol. 2020 Feb;19(2):123-134. doi: 10.1016/S1474-4422(19)30414-4. Epub 2019 Dec 20.

PMID:
31870766
11.

Implementation of the North American Neuromodulation Society Mentorship Program: Recommendations and Survey Results of Participants.

Falowski SM, Pope JE, Provenzano DA, Hanes M, Su PP, Shah J, Fishman M.

Neuromodulation. 2019 Dec 15. doi: 10.1111/ner.13068. [Epub ahead of print]

PMID:
31840350
12.

Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis.

Kuriya B, Schieir O, Valois MF, Pope JE, Boire G, Bessette L, Hazlewood G, Thorne JC, Tin D, Hitchon C, Bartlett SJ, Keystone EC, Bykerk VP, Barra L; CATCH investigators.

ACR Open Rheumatol. 2019 Aug 28;1(9):535-541. doi: 10.1002/acr2.11075. eCollection 2019 Nov. Erratum in: ACR Open Rheumatol. 2020 Jan;2(1):61. Bartlett, S [corrected to Bartlett, SJ].

13.

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years.

Pope JE, Keystone E, Jamal S, Wang L, Fallon L, Woolcott J, Lazariciu I, Chapman D, Haraoui B.

ACR Open Rheumatol. 2019 Mar 28;1(2):73-82. doi: 10.1002/acr2.1010. eCollection 2019 Apr.

14.

Association of Arthritis Onset with Influenza: Analysis of the Canadian Early Inflammatory Arthritis Cohort.

Kudaeva F, Speechley M, Klar N, Schieir O, Bartlett SJ, Bessette L, Boire G, Hazlewood G, Hitchon CA, Keystone E, Tin D, Thorne C, Bykerk VP, Pope JE; Canadian Early Arthritis Cohort (CATCH) investigators.

ACR Open Rheumatol. 2019 Mar 15;1(1):63-69. doi: 10.1002/acr2.1009. eCollection 2019 Mar.

15.

Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.

Nevskaya T, Zheng B, Baxter CA, Ramey DR, Pope JE, Baron M.

Rheumatology (Oxford). 2019 Nov 27. pii: kez529. doi: 10.1093/rheumatology/kez529. [Epub ahead of print]

PMID:
31774531
16.

Immunoglobulin G4-related disease as a mimicker of granulomatosis with polyangiitis: a case report.

Jiang Z, Wang D, Jurkiewicz M, Langdon KD, Hammond R, Fernández-Codina A, Pope JE.

Scand J Rheumatol. 2020 Mar;49(2):163-164. doi: 10.1080/03009742.2019.1672088. Epub 2019 Oct 21. No abstract available.

PMID:
31631725
17.

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 1.

18.

What is the best treatment for early rheumatoid arthritis?

Pope JE.

Rheumatology (Oxford). 2019 Dec 1;58(12):2086-2088. doi: 10.1093/rheumatology/kez353. No abstract available.

PMID:
31504929
19.

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function in Patients with Rheumatoid Arthritis in Low Disease Activity: Exploratory Analyses from RA-BEAM.

Fautrel B, Kirkham B, Pope JE, Takeuchi T, Gaich C, Quebe A, Zhu B, de la Torre I, De Leonardis F, Taylor PC.

J Clin Med. 2019 Sep 5;8(9). pii: E1394. doi: 10.3390/jcm8091394.

20.

Intrathecal Gadolinium Use for the Chronic Pain Physician.

Hagedorn JM, Bendel MA, Moeschler SM, Lamer TJ, Pope JE, Deer TR.

Neuromodulation. 2019 Oct;22(7):769-774. doi: 10.1111/ner.13043. Epub 2019 Aug 25. Review.

PMID:
31448498
21.

Raynaud's phenomenon-an update on diagnosis, classification and management.

Pauling JD, Hughes M, Pope JE.

Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16.

PMID:
31420815
22.

Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.

Zheng B, Nevskaya T, Baxter CA, Ramey DR, Pope JE, Baron M; Canadian Scleroderma Research Group .

Rheumatology (Oxford). 2020 Feb 1;59(2):398-406. doi: 10.1093/rheumatology/kez299.

PMID:
31359048
23.

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE.

Arthritis Rheumatol. 2020 Jan;72(1):125-136. doi: 10.1002/art.41055. Epub 2019 Dec 10.

PMID:
31342624
24.

Anatomic Lead Placement Without Paresthesia Mapping Provides Effective and Predictable Therapy During the Trial Evaluation Period: Results From the Prospective, Multicenter, Randomized, DELIVERY Study.

Pope JE, Schu S, Sayed D, Raslan AM, Baranidharan G, Heros RD, Blomme B, Capobianco RA, Deer TR.

Neuromodulation. 2020 Jan;23(1):109-117. doi: 10.1111/ner.13019. Epub 2019 Jul 19.

PMID:
31323175
25.

Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial.

Michaud K, Pope JE, Emery P, Zhu B, Gaich CL, DeLozier AM, Zhang X, Dickson CL, Smolen JS.

Rheumatol Ther. 2019 Sep;6(3):409-419. doi: 10.1007/s40744-019-0164-4. Epub 2019 Jun 21.

26.

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Becker M, Graf N, Sauter R, Allanore Y, Curram J, Denton CP, Khanna D, Matucci-Cerinic M, de Oliveira Pena J, Pope JE, Distler O; EUSTAR Collaborators; EUSTAR Collaborators (numerical order of centres).

Ann Rheum Dis. 2019 Sep;78(9):1242-1248. doi: 10.1136/annrheumdis-2019-215145. Epub 2019 Jun 21.

27.

The frequency of uveitis in patients with juvenile inflammatory rheumatic diseases.

Hayworth JL, Turk MA, Nevskaya T, Pope JE.

Joint Bone Spine. 2019 Nov;86(6):685-690. doi: 10.1016/j.jbspin.2019.06.001. Epub 2019 Jun 14.

PMID:
31207292
28.

Encounters with Rheumatologists in a Publicly Funded Canadian Healthcare System: A Population-based Study.

Widdifield J, Bernatsky S, Pope JE, Ahluwalia V, Barber CEH, Eder L, Kuriya B, Ling V, Paterson JM, Thorne JC.

J Rheumatol. 2020 Mar;47(3):468-476. doi: 10.3899/jrheum.190034. Epub 2019 Jun 15.

29.

A cluster of non-tuberculosis mycobacterial infections in patients with connective tissue diseases.

Fernández-Codina A, Silverman M, Pope JE.

Med Clin (Barc). 2019 Jun 3. pii: S0025-7753(19)30305-7. doi: 10.1016/j.medcli.2019.04.011. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
31171347
30.

Treatment strategies in early rheumatoid arthritis methotrexate management: Results from a prospective cohort.

Moura CS, Schieir O, Valois MF, Thorne C, Bartlett SJ, Pope JE, Hitchon CA, Boire G, Haraoui B, Hazlewood GS, Keystone EC, Tin D, Bykerk VP, Bernatsky S; Canadian Early Arthritis Cohort (CATCH) Investigators.

Arthritis Care Res (Hoboken). 2019 May 21. doi: 10.1002/acr.23927. [Epub ahead of print]

PMID:
31112011
31.

A Meta-Analysis of Treatment for Primary Sjögren's Syndrome.

Chu LL, Cui K, Pope JE.

Arthritis Care Res (Hoboken). 2019 May 6. doi: 10.1002/acr.23917. [Epub ahead of print]

PMID:
31058469
32.

Physician Guidance on the Use of Off-Labeled Drugs in Intrathecal Drug Delivery Systems for Chronic Pain.

Deer T, Kim P, Pope JE, Hayek S, McDowell G, Mekhail N, Diwan S, Saulino M, Moeschler S, Schultz D, Gritsenko K, Prager J, Peterson EA, Staats P, Poree L, Fishman MA, Vallejo R, Calodney A, Slavin K, de Leon Cassadala O, Levy R, Buvanendran A, Sitzman BT, Sayed D, Ferrante FM, Kloth D, Gilligan CJ, Kapural L, Kloster DR, Leong M, Rosenow JM, Lamer TJ, Stearns L.

Neuromodulation. 2019 Oct;22(7):765-768. doi: 10.1111/ner.12961. Epub 2019 Apr 30. No abstract available.

PMID:
31039292
33.

Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review.

Jegatheeswaran J, Turk M, Pope JE.

Immunotherapy. 2019 Jun;11(8):737-754. doi: 10.2217/imt-2018-0178. Epub 2019 Apr 8.

PMID:
30955397
34.

Evolving patterns of reactive arthritis.

Hayes KM, Hayes RJP, Turk MA, Pope JE.

Clin Rheumatol. 2019 Aug;38(8):2083-2088. doi: 10.1007/s10067-019-04522-4. Epub 2019 Mar 27.

PMID:
30919146
35.

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W, Jordan S, Graf N, de Oliveira Pena J, Curram J, Allanore Y, Matucci-Cerinic M, Pope JE, Denton CP, Khanna D, Distler O; EUSTAR Collaborators.

Ann Rheum Dis. 2019 May;78(5):648-656. doi: 10.1136/annrheumdis-2018-213455. Epub 2019 Mar 9.

36.

Is It Time to Banish Composite Measures for Remission in Rheumatoid Arthritis?

Pope JE, Michaud K.

Arthritis Care Res (Hoboken). 2019 Oct;71(10):1300-1303. doi: 10.1002/acr.23862. Epub 2019 Sep 17. No abstract available.

PMID:
30821934
37.

A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort.

Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C, Smith CD, Tucker L, Petty R, Arbillaga H, Zummer M, Hudson M, Fortin P, Huber AM, Chedeville G, Peschken C, Pope JE.

Rheumatology (Oxford). 2019 Feb 25. pii: kez006. doi: 10.1093/rheumatology/kez006. [Epub ahead of print]

PMID:
30805629
38.

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Rheumatol. 2019 Jul;46(7):751-754. doi: 10.3899/jrheum.180784. Epub 2019 Feb 1.

39.

Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.

Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL.

J Scleroderma Relat Disord. 2018 Oct;3(3):249-252. doi: 10.1177/2397198318774307. Epub 2018 May 24.

40.

Reply.

Pope JE.

Arthritis Rheumatol. 2019 May;71(5):834-835. doi: 10.1002/art.40836. Epub 2019 Mar 20. No abstract available.

PMID:
30636095
41.

Advanced methods of spinal stimulation in the treatment of chronic pain: pulse trains, waveforms, frequencies, targets, and feedback loops.

Maheshwari A, Pope JE, Deer TR, Falowski S.

Expert Rev Med Devices. 2019 Feb;16(2):95-106. doi: 10.1080/17434440.2019.1567325. Epub 2019 Jan 21. Review.

PMID:
30625000
42.

Comparison of Paresthesia Coverage of Patient's Pain: Dorsal Root Ganglion vs. Spinal Cord Stimulation. An ACCURATE Study Sub-Analysis.

Deer TR, Levy RM, Kramer J, Poree L, Amirdelfan K, Grigsby E, Staats P, Burgher AH, Scowcroft J, Golovac S, Kapural L, Paicius R, Pope JE, Samuel S, Porter McRoberts W, Schaufele M, Burton AW, Raza A, Agnesi F, Mekhail N.

Neuromodulation. 2019 Dec;22(8):930-936. doi: 10.1111/ner.12920. Epub 2019 Jan 9.

PMID:
30624003
43.

Prescribing Opioids for Severe Hip and Knee Osteoarthritis Varies Widely in the United States: The Devil Is in the Details.

Pope JE.

Arthritis Rheumatol. 2019 May;71(5):659-661. doi: 10.1002/art.40833. Epub 2019 Apr 2. No abstract available.

PMID:
30614218
44.

IgG4-Related Disease, A Single-Center Experience.

Fernández-Codina A, Haig S, Pope JE, Barra L.

J Clin Rheumatol. 2018 Dec 20. doi: 10.1097/RHU.0000000000000970. [Epub ahead of print] No abstract available.

PMID:
30585995
45.

Redefining Success: Longitudinal Patient Reported Outcome Measures and the Importance of Psychometric Testing for Optimization in Neuromodulation.

Pope JE, Fishman M.

Neuromodulation. 2019 Jan;22(1):119-120. doi: 10.1111/ner.12907. Epub 2018 Dec 13. No abstract available.

PMID:
30548940
46.

Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.

Widdifield J, Abrahamowicz M, Paterson JM, Huang A, Thorne JC, Pope JE, Kuriya B, Beauchamp ME, Bernatsky S.

J Rheumatol. 2019 May;46(5):467-474. doi: 10.3899/jrheum.180427. Epub 2018 Dec 1.

PMID:
30504508
47.

ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI).

Pope JE, Movahedi M, Rampakakis E, Cesta A, Sampalis JS, Keystone E, Thorne C, Bombardier C.

RMD Open. 2018 Nov 5;4(2):e000738. doi: 10.1136/rmdopen-2018-000738. eCollection 2018. Erratum in: RMD Open. 2019 Sep 24;5(2):e000738corr1.

48.

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.

49.

The MIST Guidelines: The Lumbar Spinal Stenosis Consensus Group Guidelines for Minimally Invasive Spine Treatment.

Deer TR, Grider JS, Pope JE, Falowski S, Lamer TJ, Calodney A, Provenzano DA, Sayed D, Lee E, Wahezi SE, Kim C, Hunter C, Gupta M, Benyamin R, Chopko B, Demesmin D, Diwan S, Gharibo C, Kapural L, Kloth D, Klagges BD, Harned M, Simopoulos T, McJunkin T, Carlson JD, Rosenquist RW, Lubenow TR, Mekhail N.

Pain Pract. 2019 Mar;19(3):250-274. doi: 10.1111/papr.12744. Epub 2018 Dec 2.

PMID:
30369003
50.

Supplemental Content

Support Center